1. Bula do produto oestrogel 2. Travassos dfa, amelia sobreira gm, clapauch r. Comparison of gel and patch estradiol replacement in brazil, a tropical country. Maturitas 2000; 36(1):6974. 3. Devogelaer, j. P., lecart, c., dupret, p., de nayer, p., & nagant de deuxchaisnes, c. (1998). Longterm effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterecto mized women. Maturitas, 28(3), 243249. 4. Baber rj, panay n, fenton a; ims writing group. 2016 ims recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; 19(2):10950. 5. Pompei, luciano de melo; machado, rogério bonassi; wender, maria celeste osório; fernandes, c. E. C. (2018). Consenso brasileiro de terapêutica hormonal da menopausa. São paulo: associação brasileira de climatério (sobrac). 6 .david f. Archer, md. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women. Menopause, 2012. 19 no. 6:622629. 7. Nappi re, biglia n, cagnacci a, et al. Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the italian vva study group. Gynecol endocrinol. 2016;32(8):6026. L’hermite, m. (2017). Bioidentical menopausal hormone therapy: registered hormones (nonoral estradiol ± progesterone) are optimal. Climacteric, 20(4), 331338. Https://doi.org/10.1080/13697137.2017.1291607 9. Vinogradova, y., coupland, c., & hippisleycox, j. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested casecontrol studies using the qresearch and cprd databases. Bmj (clinical research ed.), 364, k4810. 10. Taylor, h. S., tal, a., pal, l., li, f., black, d. M., brinton, e. A., … harman, s. M. (2017). Effects of oral vs transder mal estrogen therapy on sexual function in early postmenopause: ancillary study of the kronos early estrogen prevention study (keeps). Jama internal medicine, 177(10), 14711479. 11. Lobo ra. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60(1):108 12. Rhoda h. Cobin et al. American association of clinical endocrinologists and american college of endocrinology position statement on menopause2017 update. 2017; 23(7); 869880 13. Pinkerton joann v. Et al. The 2017 hormone therapy position statement of the north american menopause society. 2017; 24(7); 728753 14. De villiers tj, gass ml et al. Global consensus statement on menopausal hormone therapy. Climacetric.2013;16:2034 15. Bula do produto utrogestan. 16. Olié, v., canonico, m., & scarabin, p.y. (2010). Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Current opinion in hematology, 17(5), 457463.